208 related articles for article (PubMed ID: 37142961)
1. Quantitative bias analysis in practice: review of software for regression with unmeasured confounding.
Kawabata E; Tilling K; Groenwold RHH; Hughes RA
BMC Med Res Methodol; 2023 May; 23(1):111. PubMed ID: 37142961
[TBL] [Abstract][Full Text] [Related]
2. Application of quantitative bias analysis for unmeasured confounding in cost-effectiveness modelling.
Leahy TP; Duffield S; Kent S; Sammon C; Tzelis D; Ray J; Groenwold RH; Gomes M; Ramagopalan S; Grieve R
J Comp Eff Res; 2022 Aug; 11(12):861-870. PubMed ID: 35678168
[TBL] [Abstract][Full Text] [Related]
3. SAS and R code for probabilistic quantitative bias analysis for misclassified binary variables and binary unmeasured confounders.
Fox MP; MacLehose RF; Lash TL
Int J Epidemiol; 2023 Oct; 52(5):1624-1633. PubMed ID: 37141446
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
Li Y; Lee Y; Port FK; Robinson BM
Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
Kasza J; Wolfe R; Schuster T
Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
Zhang X; Stamey JD; Mathur MB
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
[TBL] [Abstract][Full Text] [Related]
8. Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied Example.
Barberio J; Ahern TP; MacLehose RF; Collin LJ; Cronin-Fenton DP; Damkier P; Sørensen HT; Lash TL
Clin Epidemiol; 2021; 13():627-635. PubMed ID: 34349564
[TBL] [Abstract][Full Text] [Related]
9. Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers.
Thorlund K; Duffield S; Popat S; Ramagopalan S; Gupta A; Hsu G; Arora P; Subbiah V
J Comp Eff Res; 2024 Mar; 13(3):e230147. PubMed ID: 38205741
[TBL] [Abstract][Full Text] [Related]
10. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
Dorie V; Harada M; Carnegie NB; Hill J
Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
[TBL] [Abstract][Full Text] [Related]
11. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity analysis for the effects of multiple unmeasured confounders.
Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
[TBL] [Abstract][Full Text] [Related]
13. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
Fewell Z; Davey Smith G; Sterne JA
Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
[TBL] [Abstract][Full Text] [Related]
14. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
[TBL] [Abstract][Full Text] [Related]
15. The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.
Leahy TP; Durand-Zaleski I; Sampietro-Colom L; Kent S; Zöllner Y; Coyle D; Casadei G
Int J Technol Assess Health Care; 2023 Nov; 39(1):e68. PubMed ID: 37981828
[TBL] [Abstract][Full Text] [Related]
16. Bespoke Instruments: A new tool for addressing unmeasured confounders.
Richardson DB; Tchetgen Tchetgen EJ
Am J Epidemiol; 2022 Mar; 191(5):939-947. PubMed ID: 34907434
[TBL] [Abstract][Full Text] [Related]
17. Examining the role of unmeasured confounding in mediation analysis with genetic and genomic applications.
Lutz SM; Thwing A; Schmiege S; Kroehl M; Baker CD; Starling AP; Hokanson JE; Ghosh D
BMC Bioinformatics; 2017 Jul; 18(1):344. PubMed ID: 28724417
[TBL] [Abstract][Full Text] [Related]
18. Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.
Streeter AJ; Lin NX; Crathorne L; Haasova M; Hyde C; Melzer D; Henley WE
J Clin Epidemiol; 2017 Jul; 87():23-34. PubMed ID: 28460857
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of quantitative bias analysis applied to epidemiological research.
Petersen JM; Ranker LR; Barnard-Mayers R; MacLehose RF; Fox MP
Int J Epidemiol; 2021 Nov; 50(5):1708-1730. PubMed ID: 33880532
[TBL] [Abstract][Full Text] [Related]
20. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
